I’ve already taken one partial profit on what was supposed to be a long-term hold for the commercialization of its Hepatitis vaccine. But then the remaining position grew too large again, especially considering that my boring long-term vaccine investment has gotten all caught up with some seedy characters. “Coronavirus Vaccine stock”? Really?
Some automated TA outfit is guiding casino patrons on this Coronavirus stock. I can just see the wild eyes and drooling mouths (wash those masks!).
This after the thing went up nicely on Friday on news of a collaboration with Mount Sinai Hospital on a would-be universal flu vaccine. That news did not bother me too much, but this thing here? I am very bothered and so I am taking my 140% well earned profit on half of the remaining position with the balance held for now.
Maybe the casino patrons will pump it higher. But my original investment reason it out the window as what I consider the seediest of characters are apparently all over it. “Coronavirus Vaccine Stock”… eff you casino patron.
An end of summer 2020 price increase is coming. Subscribe to the value-priced NFTRH now to lock in the current rate for the life of your subscription! Current subscribers will never see an increase and have never seen increases since the service began in 2008.
NFTRH Premium (monthly at USD $35.00 or a discounted yearly at USD $365.00) for an in-depth weekly market report, interim market updates and NFTRH+ chart and trade setup ideas. You can also keep up to date with actionable public content at NFTRH.com by using the email form on the right sidebar. Follow via Twitter @NFTRHgt.
